Azacitidine and lenalidomide as an alternative treatment for refractory acute myeloid leukemia: a case report

Azacitidine and lenalidomide as an alternative treatment for refractory acute myeloid leukemia: a case report

CONTEXT:Refractory acute myeloid leukemia (AML) is a difficult disease to control with second or third-line chemotherapy regimens. In this report, we describe using azacitidine in combination with lenalidomide as salvage therapy.CASE REPORT:52-year-old female was diagnosed with refractory AML and hi...

Full description

Bibliographic Details
Main Authors: Juliana Todaro, Patrícia Weinschenker Bollmann, Edna Terezinha Rother, Auro del Giglio
Format: Article
Language:English
Published: Associação Paulista de Medicina
Series:São Paulo Medical Journal
Subjects:
Leukemia, myeloid, acute
Drug therapy
Abnormal karyotype
Angiogenesis inhibitors
Azacitidine
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802015000300271&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31802015000300271&lng=en&tlng=en

Similar Items